U.S. Capital Markets Stock News

In the first quarter of 2026, AXIS Capital Holdings Limited reported revenue of US$1,643.63 million and net income of US$254.77 million, with earnings per share from continuing operations rising versus the same period a year earlier. Management credited the stronger results to disciplined underwriting, premium growth in short-tail and specialty lines, and efficiency gains from technology and AI-driven underwriting platforms, alongside continued capital return actions. Now we’ll explore how...

Darling Ingredients (NYSE:DAR) reported a fundamental turnaround in Q1 2026, returning to net profitability. Margins improved across both the core business and the Diamond Green Diesel joint venture. Management linked the shift to favorable regulation, tighter operations, and a more constructive outlook for earnings and cash flow. For investors following Darling Ingredients, the Q1 2026 results mark a clear reset in the story around NYSE:DAR. The share price sits at $63.77, with the stock...

PriceSmart, Inc. has released its Fiscal Year 2025 Sustainability Report, highlighting extensive solar power adoption across 48 of its 56 warehouse clubs and detailing plans, already announced and now underway, to open five additional clubs that would bring its network to 61 locations. The report also outlines the Women@PriceSmart program, signaling a stronger focus on workforce development and gender inclusion alongside the company’s physical expansion. We’ll now examine how PriceSmart’s...

If you are wondering whether Haemonetics at around US$59.26 is a bargain or just fairly priced right now, this article walks through what the numbers say about its value. The stock has seen mixed returns, with a 1.1% decline over the last 7 days, a 4.3% gain over 30 days, and year to date and 1 year returns of 25.9% and 7.2% declines. These movements may be prompting new questions about risk and opportunity. Recent news coverage has focused on Haemonetics as part of broader discussions...

In the first quarter of 2026, Iridium Communications Inc. reported revenue of US$219.06 million versus US$214.88 million a year earlier, while net income fell to US$21.59 million from US$30.41 million and diluted EPS from continuing operations eased to US$0.20 from US$0.27. Iridium also reiterated its 2026 outlook for total service revenue to be flat to 2%, signaling a cautious near-term growth profile despite higher quarterly sales. With Iridium reaffirming expectations for flat to slightly...

What Landstar’s latest quarter tells you Landstar System (LSTR) just released first quarter results, with sales of US$1,149.56 million and net income of US$39.44 million, and reported basic EPS from continuing operations of US$1.16. Management also highlighted heavy haul revenue, lower insurance and claims costs, AI-related initiatives, and a focus on U.S. Mexico cross border freight and carrier vetting, giving investors more context than the headline numbers alone. See our latest analysis...

How H.B. Fuller Stock Has Been Trading Recently H.B. Fuller (FUL) has seen relatively muted share performance lately, with the stock around $59.95 and negative returns over the past week, month, and past 3 months, despite a positive 1 year total return. For context, the company carries a market value of about $3.27b and generates annual revenue of roughly $3.46b with net income of about $159.76m. This reflects its role as an established adhesives and specialty chemicals supplier. See our...

Kodiak Sciences (KOD) is back in focus after sharing new KSI-101 clinical data in Asian MESI patients at the AUS and ARVO meetings, reinforcing interest in its expanding retinal disease pipeline. See our latest analysis for Kodiak Sciences. The clinical updates around KSI-101 arrive after a sharp re-rating in Kodiak Sciences, with the share price at US$43.96 and a 90-day share price return of 82.33%, contributing to a very large 1-year total shareholder return, while the 5-year total...

HCA Healthcare (NYSE:HCA) is opening a new full-service hospital in Gainesville, the first new facility of its kind in the area in more than 50 years. The company is planning a substantial expansion at Kendall Hospital in Miami-Dade, aimed at increasing capacity and service reach in South Florida. Cynthia Cifuentes-Finkel has been appointed senior vice president of marketing and corporate affairs, with responsibility for brand leadership and stakeholder engagement. For investors watching...

If you are wondering whether A10 Networks at around US$26.85 is priced attractively or already baking in a lot of optimism, this breakdown is designed to help you frame that question clearly. The stock has seen a 2.6% decline over the last 7 days, alongside returns of 11.9% over 30 days, 54.8% year to date, 65.9% over 1 year, 104.3% over 3 years and 214.4% over 5 years. These movements can change how the market views both its potential and its risks. Recent coverage has focused on A10...

Chime Financial (NasdaqGS:CHYM) has partnered with Junior Achievement USA to roll out AI powered financial literacy programs for students. The partnership includes a redesign of the JA Finance Park program to introduce interactive, experiential money management and career readiness modules. The initiative launches during Financial Literacy Month and focuses on preparing young people for real world financial decisions. For investors tracking Chime Financial, the partnership arrives as the...

Rezolve AI's SQD token has been listed on Revolut, expanding access to more than 70 million users worldwide. The listing brings SQD onto a large mainstream fintech platform, beyond crypto focused exchanges. This move is positioned as a step toward mass market adoption of Rezolve AI's decentralized AI commerce infrastructure. Rezolve AI, listed as NasdaqGM:RZLV, is building a decentralized AI commerce infrastructure designed to connect agentic AI systems with real world transactional data...

Erasca (NasdaqGS:ERAS) disclosed a patient death in its Phase 1 ERAS-0015 trial, triggering heightened safety and regulatory scrutiny. Revolution Medicines filed a patent infringement lawsuit against Erasca, also challenging the way ERAS-0015 has been compared to its own programs. These events follow a recent preliminary positive data update for ERAS-0015 and introduce fresh uncertainty around the asset and broader pipeline. Erasca comes into this twin shock with a share price of $10.03 and...

If you are trying to figure out whether Madrigal Pharmaceuticals is priced attractively today, the starting point is understanding what the current share price really reflects. The stock most recently closed at US$513.72, with returns of 0.3% over 7 days, a 6.1% decline over 30 days, a 13.5% decline year to date, a 62.8% return over 1 year, a 67.7% return over 3 years, and a very large 5 year gain of 293.9%. These mixed short term and longer term moves have kept Madrigal on the radar of...

Wondering whether Clarivate at US$2.79 is a bargain or a value trap? This article breaks down what that price really implies about the business. The stock has moved 13.9% over the last 7 days and 10.3% over the last 30 days, while the year to date return is 13.9% and the 1 year return is 35.4%. Recent coverage has focused on Clarivate's role within professional services and the information solutions space, with attention on how its products fit into clients' long term workflows and budgets...

TFS Financial Corporation has reported past second-quarter 2026 results, with net interest income rising to US$77.81 million and net income to US$23.25 million, while earnings per share reached US$0.08, up from US$0.07 a year earlier. Behind these steady figures, the bank’s higher yields from resetting Smart Rate ARMs and tight deposit cost control underpinned record net interest income and a strong Tier 1 capital position. We’ll now look at how this earnings stability, underpinned by...

Lazard (LAZ) has just posted its Q1 2026 update, with the most recent full quarter of detail showing Q4 2025 revenue of US$892.6 million and basic EPS of US$0.49, alongside trailing twelve month revenue of about US$3.1 billion and EPS of US$2.37. Over the past few reported quarters, revenue has moved from US$811.4 million in Q4 2024 to US$892.6 million in Q4 2025, while basic EPS shifted from US$0.89 to US$0.49. This sets up a results season where revenue scale and pressure on per share...

Fulton Financial Corporation recently completed a US$300,000,000 fixed‑to‑floating rate subordinated notes offering due May 15, 2036, with callable, unsecured, variable-rate features, primarily to refinance US$195,000,000 of subordinated notes due 2030 and support general corporate purposes. This refinancing reshapes the bank’s funding mix and interest-rate profile, offering investors fresh insight into how management balances capital flexibility, cost of debt, and future funding...

DT Midstream, Inc. reported past first‑quarter 2026 results with sales of US$336 million and net income of US$130 million, while also approving new pipeline expansion projects and affirming 2026 guidance. The Board’s declaration of a US$0.88 per share dividend and commitment to a larger organic project backlog underscores management’s confidence in long-term cash generation. We’ll now examine how the stronger earnings and approved Vector and Millennium pipeline expansions influence DT...

Ryder System (R) is back in focus after raising its full year 2026 earnings guidance following first quarter results that leaned on long term contracts, while also reaffirming its regular quarterly dividend. See our latest analysis for Ryder System. The raised guidance, steady dividend and ongoing share repurchases come after a strong run, with a 30 day share price return of 21.38% and a 1 year total shareholder return of 76.21%. This suggests momentum has been building around Ryder System’s...

Wondering whether Bread Financial Holdings at around US$85 a share still offers value or if most of the opportunity is already reflected in the price? This article focuses squarely on what the current valuation might be telling you. The stock has shown mixed short term moves, with a 1% decline over the last 7 days, a 16.9% return over the past month, and a 13.3% return year to date, sitting alongside a 77.0% return over the last year and a 262.6% return over three years, compared with a 6.5%...

If you are wondering whether Pitney Bowes at around US$15.53 is still a value opportunity or already pricing in a lot of optimism, the next sections will break that question down in plain terms. The stock has been volatile recently, with a 0.3% decline over the last 7 days, a 40.8% gain over 30 days, 50.3% year to date, 77.5% over 1 year, and a very large 3 year return that is close to 5x, along with a 146.6% return over 5 years. Recent headlines around Pitney Bowes have focused on its...

Wondering whether SS&C Technologies Holdings is attractively priced or just fairly valued at around US$69.29? This article breaks down what that share price could mean for you. The stock has moved 3.0% over the last 7 days and 1.4% over the last 30 days, yet is still showing a year to date return of a 19.2% decline and a 1 year return of a 9.7% decline, with a 3 year return of 30.6% and a 5 year return of 0.9%. Recent coverage has focused on SS&C Technologies Holdings as a major player in...

NNN REIT (NNN) just posted its first quarter 2026 results, reporting revenue of US$240.01 million, earnings per share of US$0.87, and management raising full year AFFO and Core FFO guidance. See our latest analysis for NNN REIT. Following the guidance raise and solid first quarter metrics, NNN REIT’s share price has gained 6.03% over the past 90 days and delivered an 11.50% 1 year total shareholder return, suggesting momentum has been building rather than fading. If this kind of steady real...